XSXuan Shao

Xuan Shao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xuan Shao has a total of 123 co-authors. Here are the top co-authors by number of shared publications:

  • Yan-Ling Wang

    State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences , Beijing 100101

    28 shared publications
  • Yu-Xia Li

    State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China

    11 shared publications
  • Yongqing Wang

    10 shared publications
  • Xin Yu

    State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China

    9 shared publications
  • Ming Liu

    International Society of Zoological Sciences Beijing China

    8 shared publications
  • Feiyang Wang

    6 shared publications

Latest Publications

  • Open Access

    Integrated RNA sequencing identifies NPM1–YAP axis dysregulation as a driver of impaired syncytialization in preeclampsia

    by Qian Yang, Qianqian Li, Feiyang Wang, Yang Hu, Yuelin Zhu, Yeling Ma, Yongqing Wang, Xuan Shao, Yan-Ling Wang, Jian Wang

  • Open Access

    Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis

    by Yun Yang, Shanshan Zhang, Xiao Fang, Tengqi Shao, Xuan Shao, Yan-Ling Wang

    The human placenta serves as the predominant endocrine organ throughout pregnancy, assuming a central role in preserving endocrine homeostasis, facilitating maternal physiological adaptation, and safeguarding fetal well-being. Preeclampsia (PE), a multifaceted and systemic gestational complication, stands as a primary contributor to maternal and perinatal morbidity and mortality. Defective placental development has been extensively acknowledged as the fundamental pathological foundation underlying this condition. Accumulating evidence has unveiled a disruption in the balance of steroid hormone production within placentas affected by early-onset PE (E-PE). Considerable endeavors have been undertaken to decipher the endocrine mechanisms driving E-PE. Recent investigations have illuminated a complex, multitiered regulatory system that governs placental steroidogenesis, encompassing epigenetic controls such as microRNA activity and metabolic flux-conjugated histone acetylation, posttranslational modifications including O-linked β-N-acetylglucosamine, as well as intricate endocrine feedback loops among steroids and other signaling molecules like melatonin. Notably, a growing body of evidence robustly supports a causal link between elevated placental testosterone synthesis and the onset of PE. Nevertheless, comprehensive studies exploring the endocrine pathophysiology of PE remain essential to illuminate novel therapeutic avenues for mitigating this adverse pregnancy outcome.


  • Open Access

    Lactate shuttle between cytotrophoblast and syncytiotrophoblast in the placenta enhances ferroptosis resistance and maintains placental homeostasis: implications for early pregnancy loss

    by Yuelin Zhu, Qianqian Li, Xin Yu, Yun Yang, Qian Yang, Yongqing Wang, Xuan Shao, Yan-Ling Wang

    The placenta serves as the interface between the mother and fetus, playing a critical role in ensuring fetal development and maternal health during pregnancy in viviparous mammals. In human placental villi, the outermost multinucleated syncytiotrophoblast (STB) are formed through the syncytialization of inner layer mononucleated cytotrophoblasts (CTBs). Despite the high cellular homeostasis exhibited by STB, the underlying mechanisms remain poorly understood. Our recent investigation into the metabolic properties of human placental trophoblasts reveals significant metabolic rewiring during syncytialization. This leads us to hypothesize that lactate produced by CTBs may be actively transported to STB, potentially protecting polyunsaturated fatty acids (PUFA)-rich STB from excessive ferroptosis, thereby contributing to the maintenance of cellular homeostasis in STB. To test this hypothesis, we conducted both in vitro and in vivo studies, utilizing clinical specimens from patients with recurrent pregnancy loss (RPL), primary cultured human CTBs and STB, induced syncytialization of trophoblast cell line BeWo, and a lipopolysaccharide (LPS)-induced mouse model of early pregnancy loss. Our data demonstrates that lactate primarily produced by CTBs can be transported to STB via monocarboxylate transporter 1 (MCT1)-mediated transport, activating the PI3K (phosphatidylinositol 3-kinase)-AKT (protein kinase B, PKB)-mTOR (mechanistic target of rapamycin) signaling pathway, and subsequently upregulating the expression of stearoyl-CoA desaturase-1 (SCD1) and glutathione peroxidase 4 (GPX4). This process mitigates lipid peroxidation and reduces ferroptosis susceptibility in STB. Administration of lactate in LPS-induced mice significantly mitigates placental ferroptosis and rescues fetal loss. Pathological analyses of the placentas from RPL (recurrent early pregnancy loss) patients demonstrates impaired lactate synthesis capacity and elevated ferroptosis biomarkers. These findings elucidate the mechanism whereby lactate shuttle between trophoblast layers suppresses ferroptosis and maintains cellular homeostasis in the placenta. The results highlight the potential therapeutic utility of lactate for addressing severe pregnancy complications such as early pregnancy loss. RPL, typically characterized by three or more consecutive spontaneous pregnancy loss before 24 weeks of gestational age, imposes profound physical and psychological burdens on affected women. Despite advances in assisted reproductive technologies (ART), IVF/ICSI cycles often fail to improve live birth rates in RPL patients, as studies show no significant reduction in miscarriage rates even with embryo selection or hormonal support. The clinical dilemma stems from over 50% of RPL cases remaining idiopathic after exhaustive evaluations, leaving limited evidence-based therapeutic options such as progesterone supplementation or immunomodulation with inconsistent efficacy. Emerging evidence highlights placental villi dysfunction as a pivotal contributor to RPL pathogenesis, and underscores targeting placental resilience pathways as promising therapeutic avenues to break the cycle of recurrent losses. Our findings uncover the mechanism by which placental STB maintain cellular homeostasis through metabolic crosstalk with CTBs. The intricate regulation of cellular homeostasis is essential for in utero fetal development. We find that impaired lactate production and transportation in the placenta from human RPL patients are strongly associated with excessive ferroptosis and fetal mortality. In a mouse model with early pregnancy loss, appropriate lactate supplementation significantly improves fetal survival rate. These findings underscore the potential therapeutic utility of this metabolite for addressing severe pregnancy complications such as RPL. Given lactate’s established safety in obstetrics and the urgent need for targeted RPL interventions, our work proposes metabolic intervention as a paradigm-shifting, pathology-guided strategy to address RPL pathogenesis. This study therefore bridges evolutionary adaptation with clinical translatability, offering a novel therapeutic framework grounded in placental metabolic resilience.


  • Open Access

    Maternal Nutritional Status Governs Fetal Development by Modulating Imprinting Gene GAB1 ‐Mediated Trophoblast Differentiation in the Placenta

    by Mingming Fan, Hongyu Wu, Yuan Xie, Ming Liu, Xin Yu, Feiyang Wang, Zhenyu Xiao, Hongmei Wang, Xuan Shao, Yan‐Ling Wang

    The appropriate allocation of nutrients between the mother and the fetus during mammalian pregnancy primarily depends on a healthy placenta. Fetal growth restriction (FGR) is frequently associated with inadequate maternal nutrition supply and impaired placental function. The precise mechanisms linking maternal nutrient deficiency to compromised fetal and placental development remain largely elusive. In this study, we conducted an in‐depth analysis by integrating single‐cell/single‐nucleus RNA sequencing data from human and mouse placentas along with transcriptomic data from FGR placenta, identifying the GAB1 (GRB2‐associated binding protein 1) gene as a potential mediator of dysregulated maternal–fetal exchange, thereby affecting fetal growth. Using a mouse model, we demonstrated that food restriction significantly impeded fetal growth and disrupted placental labyrinth development. Through an in vitro trophoblast differentiation model, we revealed that nutritional restriction impaired GAB1 stability via LC3‐interacting region (LIR) motif‐mediated selective autophagic degradation, thereby hindering GAB1‐MAPK signalling‐enhanced trophoblast syncytialisation. These findings elucidate the mechanisms by which placental GAB1 links maternal nutrition status with fetal growth and suggest potential therapeutic strategies for managing pregnancy complications such as FGR.


  • Open Access

    Hypoxia‐Induced O‐GlcNAcylation of GATA3 Leads to Excessive Testosterone Production in Preeclamptic Placentas

    by Juan Liu, Yun Yang, Hongyu Wu, Feihong Dang, Xin Yu, Feiyang Wang, Yongqing Wang, Yangyu Zhao, Xiaoming Shi, Wei Qin, et al.

    The maintenance of endocrine homeostasis in the placenta is crucial for ensuring successful pregnancy. An abnormally elevated production of placental testosterone (T0) has been documented in patients with early‐onset preeclamptic (E‐PE). However, the underlying mechanisms remain unclear. In this study, we found that E‐PE placentas exhibited significantly increased expressions of 3β‐HSD1 (3β‐Hydroxysteroid Dehydrogenase 1) and 17β‐HSD3 (17β‐Hydroxysteroid Dehydrogenase 3), the rate‐limiting enzymes for T0 synthesis. This was strongly correlated with an elevated level of O‐linked N‐acetylglucosaminylation (O‐GlcNAcylation) of GATA3 (GATA binding protein 3). In human trophoblast cells, O‐linked‐N‐acetylglucosamine (O‐GlcNAc) modification of GATA3 on Thr322 stabilized the protein and enhanced the transcriptional regulation of 3β‐HSD1 and 17β‐HSD3, thereby increasing T0 production. Hypoxia, a well‐established pathological factor in PE, significantly enhanced the O‐GlcNAcylation of GATA3 in human trophoblast cells. Our findings suggest that hypoxia‐induced overactive O‐GlcNAcylation of GATA3 contributes to the exacerbated T0 production in E‐PE placentas. These findings provide a new perspective on the pathogenesis of E‐PE from the standpoint of posttranslational regulation and may illuminate novel therapeutic strategies for adverse pregnancy outcomes such as E‐PE.


  • Open Access

    TFEB safeguards trophoblast syncytialization in humans and mice

    by Wanshan Zheng, Yue Zhang, Peiqun Xu, Zexin Wang, Xuan Shao, Chunyan Chen, Han Cai, Yinan Wang, Ming-An Sun, Wenbo Deng, et al.

    Nutrient sensing and adaptation in the placenta are essential for pregnancy viability and proper fetal growth. Our recent study demonstrated that the placenta adapts to nutrient insufficiency through mechanistic target of rapamycin (mTOR) inhibition–mediated trophoblast differentiation toward syncytiotrophoblasts (STBs), a highly specialized multinucleated trophoblast subtype mediating extensive maternal–fetal interactions. However, the underlying mechanism remains elusive. Here, we unravel the indispensable role of the mTORC1 downstream transcriptional factor TFEB in STB formation both in vitro and in vivo. TFEB deficiency significantly impaired STB differentiation in human trophoblasts and placenta organoids. Consistently, systemic or trophoblast-specific deletion of Tfeb compromised STB formation and placental vascular construction, leading to severe embryonic lethality. Mechanistically, TFEB conferred direct transcriptional activation of the fusogen ERVFRD-1 in human trophoblasts and thereby promoted STB formation, independent of its canonical function as a master regulator of the autophagy-lysosomal pathway. Moreover, we demonstrated that TFEB directed the trophoblast syncytialization response driven by mTOR complex 1 (mTORC1) signaling. TFEB expression positively correlated with the reinforced trophoblast syncytialization in human fetal growth–restricted placentas exhibiting suppressed mTORC1 activity. Our findings substantiate that the TFEB-fusogen axis ensures proper STB formation during placenta development and under nutrient stress, shedding light on TFEB as a mechanistic link between nutrient-sensing machinery and trophoblast differentiation.